Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Apr 04, 2024

SELL
$57.89 - $64.73 $24,198 - $27,057
-418 Closed
0 $0
Q2 2023

Apr 04, 2024

BUY
$63.71 - $70.74 $191 - $212
3 Added 0.72%
418 $26.7 Million
Q1 2023

Apr 04, 2024

BUY
$65.71 - $74.53 $27,269 - $30,929
415 New
415 $28.7 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Financial Synergies Wealth Advisors, Inc. Portfolio

Follow Financial Synergies Wealth Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Synergies Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Synergies Wealth Advisors, Inc. with notifications on news.